Providence Holy Cross Cancer Services Annual Patient Outcomes Analysis 2005

The Providence Holy Cross Cancer Program continues to grow at a rate of eight percent per year.It is projected that with the opening of Providence Santa Clarita outpatient center, summer of 2005, our case load will increase by 10% annually. PHCMC Cancer Program was surveyed in 2002 and a three-year approval was granted and the category was upgraded from Community Cancer Program to a Comprehensive Cancer Program.

Providence Holy Cross major sites for 2003 were breast cancer (22%), prostate cancer (11.3%) colorectal cancer (11%), lung cancer (10.5%) and lymphoma (4.7%). By far the largest proportion of new cancer patients at Providence Holy Cross are diagnosed with breast carcinoma. This group comprised 22% of analytic cases admitted in 2003 compared to 15.9% of new diagnosed cases seen in the U.S.A. Conversely, new lung cancer cases were lower, 10.5%, at PHCMC, compared with 12.8% nationwide. The percentage of new colorectal cancer cases diagnosed in the United States and Providence Holy Cross were both at 11%. Lymphoma cases represented 4.7%, higher than 4.0% seen at the national level.

The PHCMC primary site table demonstrates the multiple different sites diagnosed and treated by the Providence Holy Cross cancer program in 2003.